These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. Wooley PH, Griffin J, Panayi GS, Batchelor JR, Welsh KI, Gibson TJ. N Engl J Med; 1980 Aug 07; 303(6):300-2. PubMed ID: 6770269 [Abstract] [Full Text] [Related]
3. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine. Domljan Z, Borso G, Marinković M, Winter Fudurić I, Pucar I, Cikes N. Acta Med Iugosl; 1987 Aug 07; 41(5):363-72. PubMed ID: 3128058 [No Abstract] [Full Text] [Related]
6. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA. Pachoula-Papasteriades C, Boki K, Varla-Leftherioti M, Kappos-Rigatou I, Fostiropoulos G, Economidou J. Dis Markers; 1986 Jun 07; 4(1-2):35-41. PubMed ID: 3133153 [Abstract] [Full Text] [Related]
12. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy. Munthe E, Kåss E. J Rheumatol Suppl; 1981 Jun 07; 7():107-11. PubMed ID: 6785435 [Abstract] [Full Text] [Related]